Beijing Centergate Technologies Holding Co Ltd - Asset Resilience Ratio
Beijing Centergate Technologies Holding Co Ltd (000931) has an Asset Resilience Ratio of 0.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Beijing Centergate Technologies Holding (000931) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Beijing Centergate Technologies Holding Co Ltd's Asset Resilience Ratio has changed over time. See Beijing Centergate Technologies Holding book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Beijing Centergate Technologies Holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Beijing Centergate Technologies Holding stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.17 Million | 0.06% |
| Total Liquid Assets | CN¥2.17 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Beijing Centergate Technologies Holding Co Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Beijing Centergate Technologies Holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Centergate Technologies Holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for Beijing Centergate Technologies Holding Co Ltd (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Centergate Technologies Holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.06% | CN¥2.17 Million ≈ $318.04K |
CN¥3.71 Billion ≈ $543.19 Million |
-0.01pp |
| 2023-12-31 | 0.07% | CN¥2.76 Million ≈ $403.99K |
CN¥3.78 Billion ≈ $552.91 Million |
-0.06pp |
| 2022-12-31 | 0.13% | CN¥4.70 Million ≈ $687.52K |
CN¥3.54 Billion ≈ $518.39 Million |
0.00pp |
| 2021-12-31 | 0.13% | CN¥4.97 Million ≈ $726.55K |
CN¥3.70 Billion ≈ $541.02 Million |
-0.04pp |
| 2020-12-31 | 0.17% | CN¥5.96 Million ≈ $871.78K |
CN¥3.46 Billion ≈ $505.59 Million |
+0.02pp |
| 2019-12-31 | 0.15% | CN¥5.41 Million ≈ $792.17K |
CN¥3.58 Billion ≈ $524.17 Million |
-0.01pp |
| 2011-12-31 | 0.16% | CN¥7.00 Million ≈ $1.02 Million |
CN¥4.33 Billion ≈ $634.00 Million |
-0.09pp |
| 2003-12-31 | 0.25% | CN¥18.93 Million ≈ $2.77 Million |
CN¥7.46 Billion ≈ $1.09 Billion |
-0.15pp |
| 2002-12-31 | 0.40% | CN¥29.67 Million ≈ $4.34 Million |
CN¥7.40 Billion ≈ $1.08 Billion |
-0.17pp |
| 2001-12-31 | 0.57% | CN¥55.03 Million ≈ $8.05 Million |
CN¥9.69 Billion ≈ $1.42 Billion |
-1.91pp |
| 2000-12-31 | 2.48% | CN¥163.85 Million ≈ $23.98 Million |
CN¥6.60 Billion ≈ $966.39 Million |
-6.64pp |
| 1999-12-31 | 9.13% | CN¥285.00 Million ≈ $41.70 Million |
CN¥3.12 Billion ≈ $457.02 Million |
-- |
About Beijing Centergate Technologies Holding Co Ltd
Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more